Adaptin Bio (APTN) Profit After Tax (2023 - 2026)
Adaptin Bio (APTN) posted Profit After Tax of -$1.1 million for Q1 2026, up 16.22% sequentially from -$1.4 million in Q4 2025, and down 90.04% YoY from -$11.5 million in Q1 2025.
Adaptin Bio (APTN) Profit After Tax (2023 - 2026) Analysis & Trends
Adaptin Bio has reported Profit After Tax for 4 years, with the latest figure at -$1.1 million in Q1 2026.
- Quarterly Profit After Tax fell 90.04% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.7 million (down 68.64% YoY) and the FY2025 annual result came in at -$5.2 million, down 65.49% from the prior year.
- Profit After Tax improved to -$1.1 million in Q1 2026 per APTN's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$34155.0 in Q4 2023 and troughed at -$1.7 million in Q3 2025.
- A 4-year average of -$864846.8 and a median of -$856836.0 in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax plunged 2479.42% in 2024, then tumbled 51.29% in 2025.
- Over 4 years, Profit After Tax stood at -$34155.0 in 2023, then slumped by 2408.67% to -$856836.0 in 2024, then plunged by 59.66% to -$1.4 million in 2025, then grew by 16.22% to -$1.1 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$1.1 million, -$1.4 million, and -$1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.21 Mn |
| Mar 31, 2026 | -1.15 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.68 Mn |
| Jun 30, 2025 | -1.52 Mn |
| Mar 31, 2025 | -603,084.00 |
| Dec 31, 2024 | -856,836.00 |
| Sep 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -818,738.00 |
| Mar 31, 2024 | -339,432.00 |
| Dec 31, 2023 | -34,155.00 |
| Sep 30, 2023 | -42,938.00 |